10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2012 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 27, 2013) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
Cash flows from operating activities: | |||
Net income | $ 4,345 | 3,683 | 4,627 |
Depreciation and amortization | 1,088 | 1,060 | 1,017 |
Stock-based compensation expense | 362 | 341 | 353 |
Deferred income taxes | 28 | (328) | (151) |
Property, plant and equipment impairments | 178 | 6 | 118 |
Other items, net | (74) | 63 | 140 |
Changes in operating assets and liabilities, net of acquisitions: | |||
Trade receivables, net | 348 | (557) | (210) |
Inventories | (150) | (383) | 153 |
Other assets | 124 | (204) | 20 |
Accounts payable | 161 | (95) | 142 |
Accrued income taxes | 87 | (20) | (656) |
Legal reserve | (780) | 780 | 0 |
Other liabilities | 165 | 773 | 234 |
Net cash provided by operating activities | 5,882 | 5,119 | 5,787 |
Cash flows from investing activities: | |||
Purchases of property, plant and equipment | (689) | (567) | (580) |
Cash paid for acquisitions, net of cash acquired | (2,390) | (701) | 0 |
Purchases of marketable securities | (26,241) | (21,183) | (14,602) |
Proceeds from sales of marketable securities | 17,372 | 20,871 | 10,485 |
Proceeds from maturities of marketable securities | 1,994 | 749 | 642 |
Other | (36) | 45 | (97) |
Net cash used in investing activities | (9,990) | (786) | (4,152) |
Cash flows from financing activities: | |||
Net proceeds from issuance of debt | 4,933 | 10,387 | 2,471 |
Repayment of debt | (123) | (2,500) | 0 |
Net proceeds from issuance of commercial paper | 0 | 762 | 0 |
Repayments of commercial paper | 0 | (762) | 0 |
Repurchases of common stock | (4,607) | (8,315) | (3,786) |
Dividends paid | (1,118) | (500) | 0 |
Net proceeds from issuance of common stock in connection with the Company's equity award programs | 1,288 | 242 | 80 |
Other | 46 | 12 | 3 |
Net cash provided by (used in) financing activities | 419 | (674) | (1,232) |
Increase (decrease) in cash and cash equivalents | (3,689) | 3,659 | 403 |
Cash and cash equivalents at beginning of period | 6,946 | 3,287 | |
Cash and cash equivalents at end of period | 3,257 | 6,946 | 3,287 |
External Links | |
AMGEN INC (AMGN) Fiscal Year 2012 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |